514MO Acquired mechanisms of resistance to first-line (1L) osimertinib with or without platinum-based chemotherapy (CT) in EGFR-mutated (EGFRm) advanced NSCLC: Preliminary data from FLAURA2

Chee Khoon Lee, Jacqulyne Robichaux, Pasi A. Jänne, S-W. Kim, T.M. Kim, Kunihiko Kobayashi, David Planchard, S. Sugawara, Noriko Yanagitani, T-Y. Yang, A. Markovets, P. Bhetaryia, L. Poole, Yuri Rukazenkov, Ryan J. Hartmaier, James Chih‐Hsin Yang